Therapeutic Effect of Hijamah (Cupping Therapy) on Lipid Profiles and Apolipoprotein in Hypercholesterolemic Patients

Hijamah or cupping therapy has a therapeutic effect on cholesterol. However, there is still lack of studies that investigate the potential in managing apolipoprotein B as proatherogenic agent and A-1 an anti-proatherogenic agent. This study aims to explore lipid profiles apolipoproteins hypercholesterolemic patients. A pre-post experimental design without controls were used. Consecutive sampling was applied 40 dyslipidemia respondents. The plasma A-I (ApoA-I) (ApoB) measured after respondents fasted for 12 hours before 24 therapy. Wilcoxon sign-rank test used data analysis. following results found: average profile (mg/dL) (µg/mL) pre vs post cupping: Total Cholesterol (Pre-test Post-test) 328 283 (P-value 0.003); TG 238 204 (P- value 0.007); HDL 78.5 85 0.000); LDL 195 158 0.001); ApoA-1 0.07 0.67 ApoB 2.04 1.82 1.000); ApoB/ApoA-1 ratio 30.22 2.93 cholesterol/HDL 4.06 3.08 0.332); TG/HDL 3.01 2.83 0.104); LDL/ApoB 90.75 83.82 0.0837). In conclusion, reduces total cholesterol, TG, LDL, apoB/ApoA-1 increases significantly dyslipidemic Nurses are suggested include (hijamah) their intervention reducing hypercholesterolemia